FDA Requests Recall of Florida Compounder’s Sterile Products

Acting FDA Commissioner Ned Sharpless flagged “significant quality and sterility concerns” surrounding a Melbourne, Florida outsourcing facility on Tuesday, as the agency sought a recall of all sterile products compounded at the facility.
Source: Drug Industry Daily